These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25493603)

  • 21. [German-Austrian guidelines for HIV therapy during pregnancy (May, 2001, update].
    Buchholz B; ;
    Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S19-31. PubMed ID: 12736864
    [No Abstract]   [Full Text] [Related]  

  • 22. The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.
    Scarsi KK; Postelnick MJ
    J Gend Specif Med; 2003; 6(1):7-16. PubMed ID: 12661172
    [No Abstract]   [Full Text] [Related]  

  • 23. Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin.
    Jørgensen S; Leth S; Sommerfelt M; Østergaard L; Tolstrup M; Søgaard OS
    AIDS; 2018 Jul; 32(12):1729-1731. PubMed ID: 30001247
    [No Abstract]   [Full Text] [Related]  

  • 24. Late pregnancy screening for human immunodeficiency virus.
    Steele RW
    Pediatr Infect Dis J; 2011 Jan; 30(1):72-4. PubMed ID: 20686432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of mother to child HIV transmission.
    Duran AS; Ivalo SA; Hakim A; Masciottra FM; Zlatkes R; Adissi L; Neaton JD; Losso MH
    Medicina (B Aires); 2006; 66(1):24-30. PubMed ID: 16555724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing perinatal transmission of HIV: your vigilance can pay off.
    Tolle MA
    J Fam Pract; 2010 Mar; 59(3):E1. PubMed ID: 20230730
    [No Abstract]   [Full Text] [Related]  

  • 27. Avoiding HIV and dying of syphilis.
    Peeling RW; Mabey D; Fitzgerald DW; Watson-Jones D
    Lancet; 2004 Oct 30-Nov 5; 364(9445):1561-3. PubMed ID: 15519615
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of antiretroviral therapy in neonates, children, and adolescents.
    Neely M; Kovacs A
    Curr HIV/AIDS Rep; 2004 Jun; 1(2):97-104. PubMed ID: 16091229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategic approaches to decrease breast milk transmission of HIV-1: the importance of small things.
    John-Stewart GC
    J Infect Dis; 2009 Nov; 200(10):1487-9. PubMed ID: 19832113
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiretroviral pharmacology: special issues regarding pregnant women and neonates.
    Mirochnick M; Best BM; Clarke DF
    Clin Perinatol; 2010 Dec; 37(4):907-27, xi. PubMed ID: 21078458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.
    Grosch-Woerner I; Puch K; Maier RF; Niehues T; Notheis G; Patel D; Casteleyn S; Feiterna-Sperling C; Groeger S; Zaknun D;
    HIV Med; 2008 Jan; 9(1):6-13. PubMed ID: 18199167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of low birthweight infants in HIV-infected women delivered in Rajavithi Hospital.
    Asavapiriyanont S; Kasiwat S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S66-70. PubMed ID: 21717881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updated recommendations for reducing vertical HIV transmission.
    Paul SM; Burr CK; DiFerdinando GT
    N J Med; 2003 Sep; 100(9 Suppl):27-31; quiz 69-70. PubMed ID: 14556600
    [No Abstract]   [Full Text] [Related]  

  • 34. Feeding of infants of HIV-positive mothers.
    Saloojee H; Cooper PA
    Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):336-43. PubMed ID: 20125000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
    Román-Poueriet JA; Kley NC; Beck-Sagué CM
    N Engl J Med; 2008 Oct; 359(17):1845; author reply 1846-8. PubMed ID: 18946073
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
    Kesho Bora Study Group
    Contemp Clin Trials; 2011 Jan; 32(1):74-85. PubMed ID: 20854932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral reduction: is it time to rethink the unthinkable?
    Colasanti J; Marconi VC; Taiwo B
    AIDS; 2014 Apr; 28(7):943-7. PubMed ID: 24401641
    [No Abstract]   [Full Text] [Related]  

  • 39. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV.
    Hawkins D; Blott M; Clayden P; de Ruiter A; Foster G; Gilling-Smith C; Gosrani B; Lyall H; Mercey D; Newell ML; O'Shea S; Smith R; Sunderland J; Wood C; Taylor G;
    HIV Med; 2005 Jul; 6 Suppl 2():107-48. PubMed ID: 16033339
    [No Abstract]   [Full Text] [Related]  

  • 40. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.